Luigi Pira

887 total citations
19 papers, 729 citations indexed

About

Luigi Pira is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Luigi Pira has authored 19 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Luigi Pira's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (6 papers). Luigi Pira is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (6 papers). Luigi Pira collaborates with scholars based in Italy, France and United Kingdom. Luigi Pira's co-authors include Paola Devoto, Gian Luigi Gessa, Giovanna Flore, Luca Pani, Giorgio Longu, Sergio Tanganelli, Marco Pistis, Luca Ferraro, Giorgio Marchese and Giada Vacca and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Psychopharmacology.

In The Last Decade

Luigi Pira

19 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigi Pira Italy 12 474 234 186 156 143 19 729
Raúl Martín‐Ruiz Spain 12 577 1.2× 198 0.8× 267 1.4× 128 0.8× 58 0.4× 13 851
Karla Drescher Germany 17 607 1.3× 166 0.7× 488 2.6× 149 1.0× 134 0.9× 31 1.0k
Th. de Boer Netherlands 12 374 0.8× 206 0.9× 220 1.2× 95 0.6× 226 1.6× 19 846
Scott D. Gleason United States 16 484 1.0× 128 0.5× 293 1.6× 83 0.5× 149 1.0× 29 722
Nicola Carfagna Italy 11 303 0.6× 153 0.7× 157 0.8× 99 0.6× 76 0.5× 20 634
Gunnar Flik Netherlands 16 417 0.9× 126 0.5× 289 1.6× 99 0.6× 104 0.7× 27 899
Deborah K. Hyslop United States 12 515 1.1× 142 0.6× 324 1.7× 106 0.7× 122 0.9× 19 900
Anne‐Marie Galzin France 20 607 1.3× 280 1.2× 411 2.2× 82 0.5× 169 1.2× 46 1.1k
J. Pérez Italy 12 427 0.9× 247 1.1× 279 1.5× 79 0.5× 292 2.0× 22 846
Giorgio Marchese Italy 15 339 0.7× 258 1.1× 177 1.0× 117 0.8× 137 1.0× 43 742

Countries citing papers authored by Luigi Pira

Since Specialization
Citations

This map shows the geographic impact of Luigi Pira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Pira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Pira more than expected).

Fields of papers citing papers by Luigi Pira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Pira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Pira. The network helps show where Luigi Pira may publish in the future.

Co-authorship network of co-authors of Luigi Pira

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Pira. A scholar is included among the top collaborators of Luigi Pira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Pira. Luigi Pira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Panayi, Fany, Lionel Bert, Laurence Danober, et al.. (2017). In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonist. European Journal of Pharmacology. 803. 1–10. 13 indexed citations
2.
3.
Pira, Luigi, et al.. (2013). Genotyping of CYP2D6 Polymorphisms by MALDI-TOF Mass Spectrometry in Sardinian People. UNICA IRIS Institutional Research Information System (University of Cagliari). 2013. 1–10. 3 indexed citations
4.
Pira, Luigi, et al.. (2012). Analysis of CYP2D6 Allele Frequencies and Identification of Novel SNPs and Sequence Variations in Sardinians. UNICA IRIS Institutional Research Information System (University of Cagliari). 2013. 1–10. 8 indexed citations
5.
Pira, Luigi, et al.. (2011). Homo sapiens haplotype 1 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*2M allele, complete cds.. UNICA IRIS Institutional Research Information System (University of Cagliari). 2 indexed citations
6.
Pira, Luigi, et al.. (2011). Homo sapiens haplotype 3 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D6*2M/CYP2D6*41 hybrid allele, complete cds.. UNICA IRIS Institutional Research Information System (University of Cagliari). 1 indexed citations
7.
Pira, Luigi, et al.. (2010). Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent. Behavioural Pharmacology. 21(7). 649–653. 6 indexed citations
8.
Pani, Luca, Luigi Pira, & Giorgio Marchese. (2007). Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy. European Psychiatry. 22(5). 267–275. 59 indexed citations
9.
Pira, Luigi, Raymond Mongeau, & Luca Pani. (2004). The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. European Journal of Pharmacology. 504(1-2). 61–64. 49 indexed citations
10.
Devoto, Paola, Giovanna Flore, Luigi Pira, Giorgio Longu, & Gian Luigi Gessa. (2004). Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. Journal of Neurochemistry. 88(4). 1003–1009. 77 indexed citations
11.
Devoto, Paola, Giovanna Flore, Luigi Pira, Giorgio Longu, & Gian Luigi Gessa. (2004). Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. European Journal of Pharmacology. 487(1-3). 105–111. 68 indexed citations
12.
Devoto, Paola, Giovanna Flore, Giorgio Longu, Luigi Pira, & Gian Luigi Gessa. (2003). Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse. 50(3). 200–205. 56 indexed citations
13.
Devoto, Paola, Giovanna Flore, Giada Vacca, et al.. (2003). Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology. 167(1). 79–84. 51 indexed citations
14.
Pistis, Marco, Luca Ferraro, Luigi Pira, et al.. (2002). Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research. 948(1-2). 155–158. 178 indexed citations
15.
Devoto, Paola, Giovanna Flore, Luigi Pira, Marco Diana, & Gian Luigi Gessa. (2002). Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Psychopharmacology. 160(2). 220–224. 56 indexed citations
16.
Dazzi, Laura, Francesca Spiga, Luigi Pira, et al.. (2001). Inhibition of stress‐ or anxiogenic‐drug‐induced increases in dopamine release in the rat prefrontal cortex by long‐term treatment with antidepressant drugs. Journal of Neurochemistry. 76(4). 1212–1220. 39 indexed citations
18.
Rubiés-Prat, J, et al.. (1987). High-Density Lipoprotein Cholesterol Subfractions in Chronic Uremia. American Journal of Kidney Diseases. 9(1). 60–65. 21 indexed citations
19.
Rubiés-Prat, J, et al.. (1987). High-Density Lipoprotein Cholesterol Sub fractions in Chronic Uremia. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026